TickerFactsScreenerDevelopers

HALOZYME THERAPEUTICS, INC. (HALO) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: -$58.46M2010: -$54.26M2011: -$19.84M2012: -$53.62M2013: -$80.43M2014: -$63.04M2015: -$27.45M2016: -$83.21M2017: $81.00M2018: -$69.33M2019: -$67.61M2020: $144.25M2021: $275.90M2022: $267.53M2023: $337.57M2024: $551.48M2025: $469.01M$469.01M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$469.01M-15.0%
2024$551.48M+63.4%
2023$337.57M+26.2%
2022$267.53M-3.0%
2021$275.90M+91.3%
2020$144.25M+313.4%
2019-$67.61M+2.5%
2018-$69.33M-185.6%
2017$81.00M+197.3%
2016-$83.21M-203.1%
2015-$27.45M+56.5%
2014-$63.04M+21.6%
2013-$80.43M-50.0%
2012-$53.62M-170.3%
2011-$19.84M+63.4%
2010-$54.26M+7.2%
2009-$58.46M—